Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dorilax in Acute Low Back Pain
NCT03508167Phase 3Withdrawn
- Sponsor
- Aché Laboratórios Farmacêuticos
- Start
- Jan 2020
- Primary completion
- Oct 2020
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of paracetamol + carisoprodol + caffeine in acute low back pain, sponsored by Aché Laboratórios Farmacêuticos. Planned start Jan 2020; status: withdrawn.
02
Drugs
paracetamol + carisoprodol + caffeine
03
Conditions
acute low back pain
Beyond the preview
Go deeper on NCT03508167.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03508167.